eClinical Solutions Market by Product (CDMS, eCOA, CTMS, RTSM, ETMF, Analytics, Safety), Delivery (Web-hosted, Licensed Enterprise, Cloud-based), End User (Pharma, Hospitals, CROs), Clinical Trial Phases (Phase I, II) & Region - Global Forecasts to 2027

Abstract
The global eClinical Solutions market is projected to reach USD 17.9 billion in 2027 from USD 9.6 billion in 2022 at a CAGR of 13.3%. Rising operational costs and regulatory requirements pertaining to clinical research studies, favorable government support & funding for clinical trials, increasing R&D expenditure on drug development by pharma-biotech companies and growing adoption of novel software solutions in clinical research are some of the major driving factors for the global eClinical solutions market.

Web-hosted (on-demand) models segment held the largest market share in 2021

Based on delivery mode, the global eClinical solutions market is segmented into web-hosted (on-demand), licensed enterprise (on-premises), and cloud-based (SaaS) models. In 2021, the web-hosted segment accounted for the largest share (55.1%) of the global eClinical solutions market. Advantages such as easy user access, reductions in cost, and faster retrieval of data are factors driving the market growth for web-hosted eClinical solutions during the forecast period.

Phase III clinical trials is expected to register the highest growth during the forecast period

Based on clinical trial phase, the eClinical solutions market has been segmented into phase I, II, III, and IV. The phase III clinical trials segment accounted for the largest share of the eClinical solutions market in 2021 and is expected to register the highest growth during the forecast period. The significant demand for eClinical solutions in phase III clinical trials is mainly attributed to the involvement of a large patient sample population size, the globalization of clinical trials, and the rising need to increase the efficiency of clinical trials.

Pharmaceutical & biopharmaceutical companies to dominate the eClinical solutions end user segment in 2021

Based on end user, the global eClinical solutions market is segmented into pharmaceutical & biopharmaceutical companies, contract research organizations, consultancy service companies, medical device manufacturers, hospitals, and academic & research institutes. The pharmaceutical & biopharmaceutical companies segment accounted for the largest share of 38.5% of the global eClinical solutions market, by end user, in 2021. The large share of this segment can primarily be attributed to factors such as increasing applications of clinical data management and analytics software during clinical trials and the availability of R&D budgets for advanced healthcare IT software.

Asia Pacific to witness the highest growth between 2022 to 2027

In 2021, North America commanded the largest share of the eClinical solutions market, however, the Asia Pacific region is estimated to record the highest CAGR of 16.3% between 2022-2027. Increasing outsourcing of clinical trial studies by large pharmaceutical & biopharmaceutical companies, the presence of a large patient population, and low operating costs of conducting clinical trials are key factors driving the growth of the eClinical solutions market in the Asia Pacific region.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 – 33%, Tier 2 – 42%, and Tier 3 – 25%
• By Designation: C-level – 29%, Director-level – 23%, and Others – 48%
• By Region: North America - 35%, Europe – 30%, APAC –26%, Rest of the World –9%

The prominent players in this market include Oracle Corporation (US), Parexel International Corporation (US), Dassault Systèmes (France), Clario (US), Datatrak International (US), Signant Health (US), 4G Clinical (US), MaxisIT (US), IBM Watson Health (US), eClinical Solutions LLC (US), Veeva Systems (US), Research Manager (US), Saama Technologies, LLC (US), Mednet (US), Anju Software, Inc (US), Medrio, Inc. (US), Castor (US), Clinipace (US), ArisGlobal (US), Quretec Ltd. (Estonia), OpenClinica, LLC (US), Advarra (US), RealTime Software Solutions, LLC (US), YPrime LLC. (US) and Vial (US).

Research Coverage
This report studies the eClinical Solutions market based on product, delivery mode, clinical trial phases, end users and region. It provides detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the growth of this market and the factors impacting market dynamics. The report includes in-depth competitive analysis and the product matrix of the prominent players in this market, along with their company profiles, product portfolios, recent developments (mergers, acquisitions, partnerships, collaborations, etc.), and key business strategies. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments in different geographies.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Content
Table of Contents

1INTRODUCTION45
1.1STUDY OBJECTIVES45
1.2MARKET DEFINITION45
1.2.1INCLUSIONS AND EXCLUSIONS46
1.2.2MARKET SEGMENTATION47
1.2.3GEOGRAPHIES COVERED47
1.2.4YEARS CONSIDERED48
1.3CURRENCY CONSIDERED48
1.4LIMITATIONS48
1.5MAJOR MARKET STAKEHOLDERS49
1.6SUMMARY OF CHANGES49
2RESEARCH METHODOLOGY51
2.1RESEARCH APPROACH51
2.2RESEARCH METHODOLOGY STEPS51
FIGURE 1ECLINICAL SOLUTIONS MARKET: RESEARCH METHODOLOGY51
2.3RESEARCH METHODOLOGY DESIGN52
FIGURE 2ECLINICAL SOLUTIONS MARKET: RESEARCH DESIGN52
2.3.1SECONDARY DATA53
2.3.1.1Secondary sources54
2.3.2PRIMARY DATA55
FIGURE 3PRIMARY SOURCES55
2.3.2.1Insights from primary experts56
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION57
2.4MARKET SIZE ESTIMATION57
FIGURE 5RESEARCH METHODOLOGY: HYPOTHESIS BUILDING57
FIGURE 6SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS58
FIGURE 7REVENUE SHARE ANALYSIS ILLUSTRATION59
FIGURE 8REVENUE ANALYSIS OF TOP 3 PUBLIC COMPANIES IN ECLINICAL SOLUTIONS MARKET (2021)59
FIGURE 9BOTTOM-UP APPROACH60
FIGURE 10ECLINICAL SOLUTIONS MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027)61
FIGURE 11CAGR PROJECTION: SUPPLY-SIDE ANALYSIS62
FIGURE 12TOP-DOWN APPROACH62
2.5MARKET BREAKDOWN & DATA TRIANGULATION63
FIGURE 13DATA TRIANGULATION METHODOLOGY63
2.6STUDY ASSUMPTIONS64
2.7LIMITATIONS64
2.7.1METHODOLOGY-RELATED LIMITATIONS64
2.7.2SCOPE-RELATED LIMITATIONS64
2.8RISK ASSESSMENT65
TABLE 1ECLINICAL SOLUTIONS MARKET: RISK ASSESSMENT65
2.9RECESSION IMPACT ON ECLINICAL SOLUTIONS MARKET65
TABLE 2GLOBAL INFLATION RATE PROJECTION, 2021–2027 (% GROWTH)66
TABLE 3US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)66
TABLE 4US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)66
3EXECUTIVE SUMMARY67
FIGURE 14ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)67
FIGURE 15ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2022 VS. 2027 (USD MILLION)68
FIGURE 16ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2022 VS. 2027 (USD MILLION)69
FIGURE 17ECLINICAL SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)69
FIGURE 18ECLINICAL SOLUTIONS MARKET: REGIONS COVERED (USD MILLION)70
4PREMIUM INSIGHTS71
4.1ECLINICAL SOLUTIONS MARKET OVERVIEW71
FIGURE 19INCREASING R&D EXPENDITURE ON DRUG DISCOVERY & DEVELOPMENT BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO DRIVE MARKET71
4.2NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE & COUNTRY (2021)72
FIGURE 20WEB-HOSTED DELIVERY MODEL ACCOUNTED FOR LARGEST SHARE IN 202172
4.3GEOGRAPHIC GROWTH OPPORTUNITIES72
FIGURE 21CHINA IS EXPECTED TO ACCOUNT FOR HIGHEST GROWTH RATE DURING FORECAST PERIOD72
5MARKET OVERVIEW73
5.1INTRODUCTION73
5.2MARKET DYNAMICS73
FIGURE 22ECLINICAL SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES73
5.2.1DRIVERS74
5.2.1.1Rising operational costs and regulatory requirements associated with clinical research studies74
5.2.1.2Growing adoption of novel software solutions in clinical research74
5.2.1.3Favorable government support and funding for clinical trials75
5.2.1.4Rising need for improved data standardization75
5.2.1.5Increasing R&D expenditure on drug development by pharma-biotech companies76
5.2.2RESTRAINTS76
5.2.2.1High implementation costs associated with eClinical solutions76
5.2.2.2Shortage of skilled professionals77
5.2.2.3Limited awareness among researchers77
5.2.3OPPORTUNITIES77
5.2.3.1Increasing clinical trials in emerging countries77
5.2.3.2Growing outsourcing of clinical trial processes to CROs78
5.2.3.3Gradual shift from manual data interpretation to real-time data analysis78
5.2.4CHALLENGES79
5.2.4.1Limited adoption in emerging countries due to budgetary constraints79
5.2.4.2Concerns regarding software reliability79
5.2.4.3Issues associated with patient privacy79
5.3ECLINICAL SOLUTIONS MARKET: ECOSYSTEM ANALYSIS80
FIGURE 23ECOSYSTEM ANALYSIS80
5.4CASE STUDIES80
5.4.1YORK TEACHING HOSPITAL EXPEDITES DATA CAPTURE PROCESSING DURING PHASE III CLINICAL STUDY80
5.4.2LSHTM AND MENAFRICAR INCORPORATE DATA CAPTURE SOFTWARE TO STUDY MENINGOCOCCAL CARRIAGE IN AFRICA80
5.4.3CLINICAL TRIALS GROUP AT UCL UTILIZES EDC SYSTEM TO CAPTURE AND VERIFY PATIENT FEEDBACK81
5.5VALUE CHAIN ANALYSIS81
FIGURE 24ECLINICAL SOLUTIONS MARKET: VALUE CHAIN ANALYSIS81
5.6PORTER'S FIVE FORCES ANALYSIS82
TABLE 5HIGH CAPITAL INVESTMENTS TO RESTRICT ENTRY OF NEW PLAYERS82
5.6.1THREAT OF NEW ENTRANTS82
5.6.2THREAT OF SUBSTITUTES82
5.6.3BARGAINING POWER OF BUYERS82
5.6.4BARGAINING POWER OF SUPPLIERS82
5.6.5INTENSITY OF COMPETITIVE RIVALRY83
5.7REGULATORY LANDSCAPE83
5.7.1NORTH AMERICA83
5.7.2EUROPE84
5.7.3ASIA PACIFIC84
5.7.4MIDDLE EAST & AFRICA85
5.7.5LATIN AMERICA85
5.8TECHNOLOGY ANALYSIS85
TABLE 6TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS85
5.9INDUSTRY TRENDS86
5.9.1RISING NUMBER OF DECENTRALIZED CLINICAL TRAILS86
5.9.2GROWING ADOPTION OF TELEMEDICINE87
5.9.3IMPACT OF BIG DATA ON HEALTHCARE87
5.10PRICING ANALYSIS87
5.10.1AVERAGE SELLING PRICE TREND ANALYSIS88
TABLE 7AVERAGE SELLING PRICE OF ECLINICAL SOLUTIONS, BY LICENSE88
5.11KEY CONFERENCES AND EVENTS FROM 2022−202388
TABLE 8ECLINICAL SOLUTIONS MARKET: LIST OF CONFERENCES AND EVENTS FROM 2022−202388
5.12KEY STAKEHOLDERS AND BUYING CRITERIA89
FIGURE 25INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS AMONG END USERS89
TABLE 9INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS AMONG END USERS89
5.12.1BUYING CRITERIA90
FIGURE 26KEY BUYING CRITERIA FOR END USERS90
TABLE 10KEY BUYING CRITERIA FOR END USERS90
6ECLINICAL SOLUTIONS MARKET, BY PRODUCT91
6.1INTRODUCTION92
TABLE 11ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)92
TABLE 12ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)93
6.2ELECTRONIC DATA CAPTURE & CLINICAL DATA MANAGEMENT SYSTEMS93
6.2.1UTILIZATION OF COST-EFFECTIVE ECLINICAL SOLUTIONS INTEGRATED WITH EDC & CDM SYSTEMS TO DRIVE MARKET93
TABLE 13ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC DATA CAPTURE & CLINICAL DATA MANAGEMENT SYSTEMS, BY REGION, 2016–2019 (USD MILLION)94
TABLE 14ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC DATA CAPTURE & CLINICAL DATA MANAGEMENT SYSTEMS, BY REGION, 2020–2027 (USD MILLION)94
TABLE 15NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC DATA CAPTURE & CLINICAL DATA MANAGEMENT SYSTEMS, BY COUNTRY, 2016–2019 (USD MILLION)95
TABLE 16NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC DATA CAPTURE & CLINICAL DATA MANAGEMENT SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)95
TABLE 17EUROPE: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC DATA CAPTURE & CLINICAL DATA MANAGEMENT SYSTEMS, BY COUNTRY, 2016–2019 (USD MILLION)95
TABLE 18EUROPE: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC DATA CAPTURE & CLINICAL DATA MANAGEMENT SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)96
TABLE 19ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC DATA CAPTURE & CLINICAL DATA MANAGEMENT SYSTEMS, BY COUNTRY, 2016–2019 (USD MILLION)96
TABLE 20ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC DATA CAPTURE & CLINICAL DATA MANAGEMENT SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)96
6.3CLINICAL TRIAL MANAGEMENT SYSTEMS97
6.3.1ABILITY TO BE DEPLOYED AS A SECURE WEB APPLICATION TO DRIVE UPTAKE97
TABLE 21ECLINICAL SOLUTIONS MARKET FOR CLINICAL TRIAL MANAGEMENT SYSTEMS, BY REGION, 2016–2019 (USD MILLION)97
TABLE 22ECLINICAL SOLUTIONS MARKET FOR CLINICAL TRIAL MANAGEMENT SYSTEMS, BY REGION, 2020–2027 (USD MILLION)98
TABLE 23NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR CLINICAL TRIAL MANAGEMENT SYSTEMS, BY COUNTRY, 2016–2019 (USD MILLION)98
TABLE 24NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR CLINICAL TRIAL MANAGEMENT SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)98
TABLE 25EUROPE: ECLINICAL SOLUTIONS MARKET FOR CLINICAL TRIAL MANAGEMENT SYSTEMS, BY COUNTRY, 2016–2019 (USD MILLION)99
TABLE 26EUROPE: ECLINICAL SOLUTIONS MARKET FOR CLINICAL TRIAL MANAGEMENT SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)99
TABLE 27ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR CLINICAL TRIAL MANAGEMENT SYSTEMS, BY COUNTRY, 2016–2019 (USD MILLION)99
TABLE 28ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR CLINICAL TRIAL MANAGEMENT SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)100
6.4CLINICAL ANALYTICS PLATFORMS100
6.4.1ABILITY TO AUTOMATE CLINICAL DEVELOPMENT ACTIVITIES TO DRIVE MARKET100
TABLE 29ECLINICAL SOLUTIONS MARKET FOR CLINICAL ANALYTICS PLATFORMS, BY REGION, 2016–2019 (USD MILLION)101
TABLE 30ECLINICAL SOLUTIONS MARKET FOR CLINICAL ANALYTICS PLATFORMS, BY REGION, 2020–2027 (USD MILLION)101
TABLE 31NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR CLINICAL ANALYTICS PLATFORMS, BY COUNTRY, 2016–2019 (USD MILLION)101
TABLE 32NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR CLINICAL ANALYTICS PLATFORMS, BY COUNTRY, 2020–2027 (USD MILLION)102
TABLE 33EUROPE: ECLINICAL SOLUTIONS MARKET FOR CLINICAL ANALYTICS PLATFORMS, BY COUNTRY, 2016–2019 (USD MILLION)102
TABLE 34EUROPE: ECLINICAL SOLUTIONS MARKET FOR CLINICAL ANALYTICS PLATFORMS, BY COUNTRY, 2020–2027 (USD MILLION)102
TABLE 35ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR CLINICAL ANALYTICS PLATFORMS, BY COUNTRY, 2016–2019 (USD MILLION)103
TABLE 36ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR CLINICAL ANALYTICS PLATFORMS, BY COUNTRY, 2020–2027 (USD MILLION)103
6.5RANDOMIZATION & TRIAL SUPPLY MANAGEMENT SYSTEMS103
6.5.1EFFECTIVE MANAGEMENT OF INVENTORY MONITORING AND RANDOMIZED PATIENT POOLS TO DRIVE ADOPTION103
TABLE 37ECLINICAL SOLUTIONS MARKET FOR RANDOMIZATION & TRIAL SUPPLY MANAGEMENT SYSTEMS, BY REGION, 2016–2019 (USD MILLION)104
TABLE 38ECLINICAL SOLUTIONS MARKET FOR RANDOMIZATION & TRIAL SUPPLY MANAGEMENT SYSTEMS, BY REGION, 2020–2027 (USD MILLION)104
TABLE 39NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR RANDOMIZATION & TRIAL SUPPLY MANAGEMENT SYSTEMS, BY COUNTRY, 2016–2019 (USD MILLION)104
TABLE 40NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR RANDOMIZATION & TRIAL SUPPLY MANAGEMENT SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)105
TABLE 41EUROPE: ECLINICAL SOLUTIONS MARKET FOR RANDOMIZATION & TRIAL SUPPLY MANAGEMENT SYSTEMS, BY COUNTRY, 2016–2019 (USD MILLION)105
TABLE 42EUROPE: ECLINICAL SOLUTIONS MARKET FOR RANDOMIZATION & TRIAL SUPPLY MANAGEMENT SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)105
TABLE 43ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR RANDOMIZATION & TRIAL SUPPLY MANAGEMENT SYSTEMS, BY COUNTRY, 2016–2019 (USD MILLION)106
TABLE 44ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR RANDOMIZATION & TRIAL SUPPLY MANAGEMENT SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)106
6.6CLINICAL DATA INTEGRATION PLATFORMS106
6.6.1ABILITY TO OPTIMIZE SECURE EXCHANGE OF EHR ON A USER-FRIENDLY GUI TO FUEL MARKET106
TABLE 45ECLINICAL SOLUTIONS MARKET FOR CLINICAL DATA INTEGRATION PLATFORMS, BY REGION, 2016–2019 (USD MILLION)107
TABLE 46ECLINICAL SOLUTIONS MARKET FOR CLINICAL TRIAL INTEGRATION PLATFORMS, BY REGION, 2020–2027 (USD MILLION)107
TABLE 47NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR CLINICAL DATA INTEGRATION PLATFORMS, BY COUNTRY, 2016–2019 (USD MILLION)108
TABLE 48NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR CLINICAL DATA INTEGRATION PLATFORMS, BY COUNTRY, 2020–2027 (USD MILLION)108
TABLE 49EUROPE: ECLINICAL SOLUTIONS MARKET FOR CLINICAL DATA INTEGRATION PLATFORMS, BY COUNTRY, 2016–2019 (USD MILLION)108
TABLE 50EUROPE: ECLINICAL SOLUTIONS MARKET FOR CLINICAL DATA INTEGRATION PLATFORMS, BY COUNTRY, 2020–2027 (USD MILLION)109
TABLE 51ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR CLINICAL DATA INTEGRATION PLATFORMS, BY COUNTRY, 2016–2019 (USD MILLION)109
TABLE 52ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR CLINICAL DATA INTEGRATION PLATFORMS, BY COUNTRY, 2020–2027 (USD MILLION)109
6.7ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS110
6.7.1INCREASING ADOPTION OF EPRO SOLUTIONS AND EDIARIES AMONG PHARMA COMPANIES TO DRIVE UPTAKE110
TABLE 53ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS, BY REGION, 2016–2019 (USD MILLION)110
TABLE 54ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS, BY REGION, 2020–2027 (USD MILLION)110
TABLE 55NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS, BY COUNTRY, 2016–2019 (USD MILLION)111
TABLE 56NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)111
TABLE 57EUROPE: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS, BY COUNTRY, 2016–2019 (USD MILLION)111
TABLE 58EUROPE: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)112
TABLE 59ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS, BY COUNTRY, 2016–2019 (USD MILLION)112
TABLE 60ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)112
6.8SAFETY SOLUTIONS113
6.8.1ABILITY TO STREAMLINE SAFETY PROCESSING PROCESSES DURING CLINICAL TRIALS TO SUPPORT MARKET GROWTH113
TABLE 61ECLINICAL SOLUTIONS MARKET FOR SAFETY SOLUTIONS, BY REGION, 2016–2019 (USD MILLION)113
TABLE 62ECLINICAL SOLUTIONS MARKET FOR SAFETY SOLUTIONS, BY REGION, 2020–2027 (USD MILLION)113
TABLE 63NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR SAFETY SOLUTIONS, BY COUNTRY, 2016–2019 (USD MILLION)114
TABLE 64NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR SAFETY SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)114
TABLE 65EUROPE: ECLINICAL SOLUTIONS MARKET FOR SAFETY SOLUTIONS, BY COUNTRY, 2016–2019 (USD MILLION)114
TABLE 66EUROPE: ECLINICAL SOLUTIONS MARKET FOR SAFETY SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)115
TABLE 67ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR SAFETY SOLUTIONS, BY COUNTRY, 2016–2019 (USD MILLION)115
TABLE 68ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR SAFETY SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)115
6.9ELECTRONIC TRIAL MASTER FILE SYSTEMS116
6.9.1RAPID SEARCH AND RETRIEVAL OF CLINICAL TRIAL DOCUMENTS WITH ETMF TO FUEL MARKET116
TABLE 69ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC TRIAL MASTER FILE SYSTEMS, BY REGION, 2016–2019 (USD MILLION)116
TABLE 70ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC TRIAL MASTER FILE SYSTEMS, BY REGION, 2020–2027 (USD MILLION)116
TABLE 71NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC TRIAL MASTER FILE SYSTEMS, BY COUNTRY, 2016–2019 (USD MILLION)117
TABLE 72NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC TRIAL MASTER FILE SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)117
TABLE 73EUROPE: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC TRIAL MASTER FILE SYSTEMS, BY COUNTRY, 2016–2019 (USD MILLION)117
TABLE 74EUROPE: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC TRIAL MASTER FILE SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)118
TABLE 75ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC TRIAL MASTER FILE SYSTEMS, BY COUNTRY, 2016–2019 (USD MILLION)118
TABLE 76ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC TRIAL MASTER FILE SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)118
6.10ELECTRONIC CONSENT SOLUTIONS119
6.10.1ABILITY TO ENSURE ADHERENCE TO ICF REGULATIONS TO INCREASE ADOPTION119
TABLE 77ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CONSENT SOLUTIONS, BY REGION, 2016–2019 (USD MILLION)119
TABLE 78ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CONSENT SOLUTIONS, BY REGION, 2020–2027 (USD MILLION)119
TABLE 79NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CONSENT SOLUTIONS, BY COUNTRY, 2016–2019 (USD MILLION)120
TABLE 80NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CONSENT SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)120
TABLE 81EUROPE: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CONSENT SOLUTIONS, BY COUNTRY, 2016–2019 (USD MILLION)120
TABLE 82EUROPE: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CONSENT SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)121
TABLE 83ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CONSENT SOLUTIONS, BY COUNTRY, 2016–2019 (USD MILLION)121
TABLE 84ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CONSENT SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)121
6.11REGULATORY INFORMATION MANAGEMENT SYSTEMS122
6.11.1ABILITY TO ASSIST RESEARCHERS IN CENTRALIZING REGULATORY INFORMATION FOR OPTIMAL STANDARDIZATION TO DRIVE MARKET122
TABLE 85ECLINICAL SOLUTIONS MARKET FOR REGULATORY INFORMATION MANAGEMENT SYSTEMS, BY REGION, 2016–2019 (USD MILLION)122
TABLE 86ECLINICAL SOLUTIONS MARKET FOR REGULATORY INFORMATION MANAGEMENT SYSTEMS, BY REGION, 2020–2027 (USD MILLION)122
TABLE 87NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR REGULATORY INFORMATION MANAGEMENT SYSTEMS, BY COUNTRY, 2016–2019 (USD MILLION)123
TABLE 88NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR REGULATORY INFORMATION MANAGEMENT SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)123
TABLE 89EUROPE: ECLINICAL SOLUTIONS MARKET FOR REGULATORY INFORMATION MANAGEMENT SYSTEMS, BY COUNTRY, 2016–2019 (USD MILLION)123
TABLE 90EUROPE: ECLINICAL SOLUTIONS MARKET FOR REGULATORY INFORMATION MANAGEMENT SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)124
TABLE 91ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR REGULATORY INFORMATION MANAGEMENT SYSTEMS, BY COUNTRY, 2016–2019 (USD MILLION)124
TABLE 92ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR REGULATORY INFORMATION MANAGEMENT SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)124
6.12OTHER ECLINICAL SOLUTIONS125
TABLE 93OTHER ECLINICAL SOLUTIONS MARKET, BY REGION, 2016–2019 (USD MILLION)125
TABLE 94OTHER ECLINICAL SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)125
TABLE 95NORTH AMERICA: OTHER ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)125
TABLE 96NORTH AMERICA: OTHER ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)126
TABLE 97EUROPE: OTHER ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)126
TABLE 98EUROPE: OTHER ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)126
TABLE 99ASIA PACIFIC: OTHER ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)127
TABLE 100ASIA PACIFIC: OTHER ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)127
7ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE128
7.1INTRODUCTION129
TABLE 101ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2016–2019 (USD MILLION)129
TABLE 102ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)129
7.2WEB-HOSTED MODELS130
7.2.1ENHANCED QUALITY OF CLINICAL TRIALS WITH IMPROVED PRODUCTIVITY TO DRIVE MARKET130
TABLE 103ECLINICAL SOLUTIONS MARKET FOR WEB-HOSTED MODELS, BY REGION, 2016–2019 (USD MILLION)130
TABLE 104ECLINICAL SOLUTIONS MARKET FOR WEB-HOSTED MODELS, BY REGION, 2020–2027 (USD MILLION)130
TABLE 105NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR WEB-HOSTED MODELS, BY COUNTRY, 2016–2019 (USD MILLION)131
TABLE 106NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR WEB-HOSTEL MODELS, BY COUNTRY, 2020–2027 (USD MILLION)131
TABLE 107EUROPE: ECLINICAL SOLUTIONS MARKET FOR WEB-HOSTED MODELS, BY COUNTRY, 2016–2019 (USD MILLION)131
TABLE 108EUROPE: ECLINICAL SOLUTIONS MARKET FOR WEB-HOSTED MODELS, BY COUNTRY, 2020–2027 (USD MILLION)132
TABLE 109ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR WEB-HOSTED MODELS, BY COUNTRY, 2016–2019 (USD MILLION)132
TABLE 110ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR WEB-HOSTED MODELS, BY COUNTRY, 2020–2027 (USD MILLION)132
7.3LICENSED ENTERPRISE MODELS133
7.3.1OPTIMAL CONTROL ON DEPLOYMENT AND DATA BACKUP TO SUPPORT MARKET UPTAKE133
TABLE 111ECLINICAL SOLUTIONS MARKET FOR LICENSED ENTERPRISE MODELS, BY REGION, 2016–2019 (USD MILLION)133
TABLE 112ECLINICAL SOLUTIONS MARKET FOR LICENSED ENTERPRISE MODELS, BY REGION, 2020–2027 (USD MILLION)134
TABLE 113NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR LICENSED ENTERPRISE MODELS, BY COUNTRY, 2016–2019 (USD MILLION)134
TABLE 114NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR LICENSED ENTERPRISE MODELS, BY COUNTRY, 2020–2027 (USD MILLION)134
TABLE 115EUROPE: ECLINICAL SOLUTIONS MARKET FOR LICENSED ENTERPRISE MODELS, BY COUNTRY, 2016–2019 (USD MILLION)135
TABLE 116EUROPE: ECLINICAL SOLUTIONS MARKET FOR LICENSED ENTERPRISE MODELS, BY COUNTRY, 2020–2027 (USD MILLION)135
TABLE 117ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR LICENSED ENTERPRISE MODELS, BY COUNTRY, 2016–2019 (USD MILLION)135
TABLE 118ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR LICENSED ENTERPRISE MODELS, BY COUNTRY, 2020–2027 (USD MILLION)136
7.4CLOUD-BASED SOLUTIONS136
7.4.1REMOTE CENTRALIZED ACCESS WITH REAL-TIME ANALYSIS TO DRIVE MARKET136
TABLE 119ECLINICAL SOLUTIONS MARKET FOR CLOUD-BASED MODELS, BY REGION, 2016–2019 (USD MILLION)137
TABLE 120ECLINICAL SOLUTIONS MARKET FOR CLOUD-BASED MODELS, BY REGION, 2020–2027 (USD MILLION)137
TABLE 121NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR CLOUD-BASED MODELS, BY COUNTRY, 2016–2019 (USD MILLION)137
TABLE 122NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR CLOUD-BASED MODELS, BY COUNTRY, 2020–2027 (USD MILLION)138
TABLE 123EUROPE: ECLINICAL SOLUTIONS MARKET FOR CLOUD-BASED MODELS, BY COUNTRY, 2016–2019 (USD MILLION)138
TABLE 124EUROPE: ECLINICAL SOLUTIONS MARKET FOR CLOUD-BASED MODELS, BY COUNTRY, 2020–2027 (USD MILLION)138
TABLE 125ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR CLOUD-BASED MODELS, BY COUNTRY, 2016–2019 (USD MILLION)139
TABLE 126ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR CLOUD-BASED MODELS, BY COUNTRY, 2020–2027 (USD MILLION)139
8ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE140
8.1INTRODUCTION141
TABLE 127ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2016–2019 (USD MILLION)141
TABLE 128ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION)141
8.2PHASE I CLINICAL TRIALS142
8.2.1ADOPTION OF EDC & CDM SYSTEMS IN PHASE I STUDIES TO DRIVE MARKET142
TABLE 129ECLINICAL SOLUTIONS MARKET FOR PHASE I, BY REGION, 2016–2019 (USD MILLION)142
TABLE 130ECLINICAL SOLUTIONS MARKET FOR PHASE I, BY REGION, 2020–2027 (USD MILLION)142
TABLE 131NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR PHASE I, BY COUNTRY, 2016–2019 (USD MILLION)143
TABLE 132NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR PHASE I, BY COUNTRY, 2020–2027 (USD MILLION)143
TABLE 133EUROPE: ECLINICAL SOLUTIONS MARKET FOR PHASE I, BY COUNTRY, 2016–2019 (USD MILLION)143
TABLE 134EUROPE: ECLINICAL SOLUTIONS MARKET FOR PHASE I, BY COUNTRY, 2020–2027 (USD MILLION)144
TABLE 135ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR PHASE I, BY COUNTRY, 2016–2019 (USD MILLION)144
TABLE 136ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR PHASE I, BY COUNTRY, 2020–2027 (USD MILLION)144
8.3PHASE II CLINICAL TRIALS145
8.3.1UTILIZATION OF ECLINICAL SOLUTIONS IN STREAMLINING PHASE II TRIALS TO BOOST MARKET145
TABLE 137ECLINICAL SOLUTIONS MARKET FOR PHASE II, BY REGION, 2016–2019 (USD MILLION)145
TABLE 138ECLINICAL SOLUTIONS MARKET FOR PHASE II, BY REGION, 2020–2027 (USD MILLION)146
TABLE 139NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR PHASE II, BY COUNTRY, 2016–2019 (USD MILLION)146
TABLE 140NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR PHASE II, BY COUNTRY, 2020–2027 (USD MILLION)146
TABLE 141EUROPE: ECLINICAL SOLUTIONS MARKET FOR PHASE II, BY COUNTRY, 2016–2019 (USD MILLION)147
TABLE 142EUROPE: ECLINICAL SOLUTIONS MARKET FOR PHASE II, BY COUNTRY, 2020–2027 (USD MILLION)147
TABLE 143ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR PHASE II, BY COUNTRY, 2016–2019 (USD MILLION)147
TABLE 144ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR PHASE II, BY COUNTRY, 2020–2027 (USD MILLION)148
8.4PHASE III CLINICAL TRIALS148
8.4.1INVOLVEMENT OF A LARGE PATIENT POPULATION TO DRIVE MARKET148
TABLE 145ECLINICAL SOLUTIONS MARKET FOR PHASE III, BY REGION, 2016–2019 (USD MILLION)149
TABLE 146ECLINICAL SOLUTIONS MARKET FOR PHASE III, BY REGION, 2020–2027 (USD MILLION)149
TABLE 147NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR PHASE III, BY COUNTRY, 2016–2019 (USD MILLION)149
TABLE 148NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR PHASE III, BY COUNTRY, 2020–2027 (USD MILLION)150
TABLE 149EUROPE: ECLINICAL SOLUTIONS MARKET FOR PHASE III, BY COUNTRY, 2016–2019 (USD MILLION)150
TABLE 150EUROPE: ECLINICAL SOLUTIONS MARKET FOR PHASE III, BY COUNTRY, 2020–2027 (USD MILLION)150
TABLE 151ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR PHASE III, BY COUNTRY, 2016–2019 (USD MILLION)151
TABLE 152ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR PHASE III, BY COUNTRY, 2020–2027 (USD MILLION)151
8.5PHASE IV CLINICAL TRIALS151
8.5.1RISING DEMAND FOR POST-MARKETING SURVEILLANCE TO SUPPORT MARKET GROWTH151
TABLE 153ECLINICAL SOLUTIONS MARKET FOR PHASE IV, BY REGION, 2016–2019 (USD MILLION)152
TABLE 154ECLINICAL SOLUTIONS MARKET FOR PHASE IV, BY REGION, 2020–2027 (USD MILLION)152
TABLE 155NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR PHASE IV, BY COUNTRY, 2016–2019 (USD MILLION)152
TABLE 156NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR PHASE IV, BY COUNTRY, 2020–2027 (USD MILLION)153
TABLE 157EUROPE: ECLINICAL SOLUTIONS MARKET FOR PHASE IV, BY COUNTRY, 2016–2019 (USD MILLION)153
TABLE 158EUROPE: ECLINICAL SOLUTIONS MARKET FOR PHASE IV, BY COUNTRY, 2020–2027 (USD MILLION)153
TABLE 159ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR PHASE IV, BY COUNTRY, 2016–2019 (USD MILLION)154
TABLE 160ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR PHASE IV, BY COUNTRY, 2020–2027 (USD MILLION)154
9ECLINICAL SOLUTIONS MARKET, BY END USER155
9.1INTRODUCTION156
TABLE 161ECLINICAL SOLUTIONS MARKET, BY END USER, 2016–2019 (USD MILLION)156
TABLE 162ECLINICAL SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)156
9.2PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES157
9.2.1INCREASING R&D EXPENDITURE FOR DRUG DISCOVERY AND DEVELOPMENT TO DRIVE MARKET157
TABLE 163ECLINICAL SOLUTIONS MARKET SIZE PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2016–2019 (USD MILLION)157
TABLE 164ECLINICAL SOLUTIONS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020–2027 (USD MILLION)158
TABLE 165NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016–2019 (USD MILLION)158
TABLE 166NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)158
TABLE 167EUROPE: ECLINICAL SOLUTIONS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016–2019 (USD MILLION)159
TABLE 168EUROPE: ECLINICAL SOLUTIONS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)159
TABLE 169ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016–2019 (USD MILLION)159
TABLE 170ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)160
9.3CONTRACT RESEARCH ORGANIZATIONS160
9.3.1RISING OUTSOURCING OF CLINICAL TRIAL ACTIVITIES TO CROS BY PHARMACEUTICAL COMPANIES TO DRIVE MARKET160
TABLE 171ECLINICAL SOLUTIONS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2016–2019 (USD MILLION)161
TABLE 172ECLINICAL SOLUTIONS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2020–2027 (USD MILLION)161
TABLE 173NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2019 (USD MILLION)161
TABLE 174NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR CROS, BY COUNTRY, 2020–2027 (USD MILLION)162
TABLE 175EUROPE: ECLINICAL SOLUTIONS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2019 (USD MILLION)162
TABLE 176EUROPE: ECLINICAL SOLUTIONS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)162
TABLE 177ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2019 (USD MILLION)163
TABLE 178ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)163
9.4CONSULTANCY SERVICE COMPANIES163
9.4.1GROWING COLLABORATIONS FOR CDM BETWEEN CONSULTANCY FIRMS AND PHARMA & BIOTECH COMPANIES TO DRIVE MARKET163
TABLE 179ECLINICAL SOLUTIONS MARKET FOR CONSULTANCY SERVICE COMPANIES, BY REGION, 2016–2019 (USD MILLION)164
TABLE 180ECLINICAL SOLUTIONS MARKET FOR CONSULTANCY SERVICE COMPANIES, BY REGION, 2020–2027 (USD MILLION)164
TABLE 181NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR CONSULTANCY SERVICE COMPANIES, BY COUNTRY, 2016–2019 (USD MILLION)164
TABLE 182NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR CONSULTANCY SERVICE COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)165
TABLE 183EUROPE: ECLINICAL SOLUTIONS MARKET FOR CONSULTANCY SERVICE COMPANIES, BY COUNTRY, 2016–2019 (USD MILLION)165
TABLE 184EUROPE: ECLINICAL SOLUTIONS MARKET FOR CONSULTANCY SERVICE COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)165
TABLE 185ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR CONSULTANCY SERVICE COMPANIES, BY COUNTRY, 2016–2019 (USD MILLION)166
TABLE 186ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR CONSULTANCY SERVICE COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)166
9.5MEDICAL DEVICE MANUFACTURERS166
9.5.1UTILIZATION OF CLINICAL DATA SOFTWARE SOLUTIONS FOR MEDICAL DEVICE TRIALS TO FUEL MARKET166
TABLE 187ECLINICAL SOLUTIONS MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2016–2019 (USD MILLION)167
TABLE 188ECLINICAL SOLUTIONS MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2020–2027 (USD MILLION)167
TABLE 189NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY COUNTRY, 2016–2019 (USD MILLION)167
TABLE 190NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY COUNTRY, 2020–2027 (USD MILLION)168
TABLE 191EUROPE: ECLINICAL SOLUTIONS MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY COUNTRY, 2016–2019 (USD MILLION)168
TABLE 192EUROPE: ECLINICAL SOLUTIONS MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY COUNTRY, 2020–2027 (USD MILLION)168
TABLE 193ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY COUNTRY, 2016–2019 (USD MILLION)169
TABLE 194ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY COUNTRY, 2020–2027 (USD MILLION)169
9.6HOSPITALS169
9.6.1INCREASING IT BUDGETS TO STREAMLINE PATIENT DATABASES TO PROPEL MARKET169
TABLE 195ECLINICAL SOLUTIONS MARKET FOR HOSPITALS, BY REGION, 2016–2019 (USD MILLION)170
TABLE 196ECLINICAL SOLUTIONS MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)170
TABLE 197NORTH AMERICA: ECLINICAL SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY, 2016–2019 (USD MILLION)170
TABLE 198NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)171
TABLE 199EUROPE: ECLINICAL SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY, 2016–2019 (USD MILLION)171
TABLE 200EUROPE: ECLINICAL SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)171
TABLE 201ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY, 2016–2019 (USD MILLION)172
TABLE 202ASIA PACIFIC: ECLINICAL SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)172
9.7ACADEMIC & RESEARCH INSTITUTES172
9.7.1FAVORABLE GOVERNMENT SUPPORT FOR CLINICAL RESEARCH TO SUPPORT MARKET GROWTH172
TABLE 203ECLINICAL SOLUTIONS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2016–2019 (USD MILLION)173
TABLE 204ECLINICAL SOLUTIONS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION)173
TABLE 20